The Patent Finder

Multi Component Antibody Based Detection Technology

Cell Signaling Technology, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2012/048587, filed Jul 27, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,588,110Multi Component Antibody Based Detection Technology
In force
 · High confidence
Cell Signaling Technology, Inc.In force
High confidence
US 10,577,640Multi Component Detection
In force
 · High confidence
Cell Signaling Technology, Inc.In force
High confidence
Application 16/800,394Multi Component Detection
Abandoned
Abandoned Mar 29, 2023
Cell Signaling Technology, Inc.AbandonedAbandoned Mar 29, 2023
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Cell Signaling Technology, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited